Table 1.

Patient demographics and survival outcome

			Survival			Progression Free Survival
		N	2yr rate ± SE	Median (months)	Log rank P value	2yr rate ± SE	Median (months)	Log rank P value
All patients		38	52%±9%	31.7		31%±8%	9.6
Gender
Male		28	41%±10%	17.8	0.07	18%±8%	8.8	0.02
Female		10	79%±13%	54.7		53%±18%	28.4
Age
< 65		18	53%±13%	54.7	0.99	27%±12%	9.0	0.31
≥ 65		20	54%±11%	31.7		34%±11%	10.3
Cell type
Epithelial		31	64%±9%	41.2	<0.001	38%±9%	15.1	<0.001
Non-epithelial		7	0%	6.8		0%	4.8
N stage
N0		9	67%±16%	57.1	0.10	56%±17%	26.9	0.21
N+(4 N1; 24 N2)		28	49%±10%	22.7		24%±9%	9.6
Unknown Nx		1
AJCC stage
1		1	--	--		--	--
3		28	50%±10%	22.7	0.83	30%±9%	9.2	0.95
4		9	52%±18%	36.6	3 vs. 4	26%±16%	10.3	3 vs. 4
Chemotherapy
None		3	67%±27%	42.5	**	67%±27%	Undefined	**
Pre-op		4	0%	2.5		0%	5.0
Post-op		25	33%±10%	9.6		58%±10%	31.7
Pre & post-op		6	17%±15%	10.3		44%±22%	22.7
N2 disease only
Cell type
Epithelial		20	55%±12%	31.7	0.001	27%±11%	15.1	<0.001
Non-epithelial		4	0%	6.8		0%	4.7

^**No comparison, patients were not randomized to treatment